Industry Best Practices

Patent systems can provide an advantage to society by rewarding the development of new inventions, promoting the advancement of technology and protecting the investor.  Patents often are the most important, and sometimes only, asset of a biotech company. Patents and related rights must be obtained in a timely and predictable manner and the ability to enforce those patents is critical.

BIO released a survey on licensing trends between universities and companies.

Letters, Testimony & Comments

March 1 2012
February 22, 2012 Texas Health and Human Services Commission Attn: Stacey Johnston Policy Analyst Medicaid/Children’s Health...
April 18 2011
Re: Docket No. FDA-2011-D-0057: Best Practices for Conducting and Reporting Pharmacoepidemiologic Safety Studies Using Electronic...
April 13 2009
Re: Docket No. FDA-2009-D-0675, OC 20091. Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug...
January 21 2009
Re: Docket No. FDA-2008-D-0559, Draft Guidance for Industry on Process Validation: General Principles and Practices; Availability...

Press Releases

January 3 2011
WASHINGTON, D.C. (Monday, January 03, 2011) - The Biotechnology Industry Organization (BIO) announced today that...
December 13 2010
WASHINGTON, D.C. (Monday, December 13, 2010) - The Biotechnology Industry Organization (BIO) today announced the...
December 1 2010
WASHINGTON, D.C. (Wednesday, December 01, 2010) - Media registration is now available online for the 13th Annual...
May 6 2010
WASHINGTON, D.C. (Thursday, May 6, 2010) - Industrial biotechnology companies are exploring algae as a potential...
July 25 2007
WASHINGTON, D.C. (July 25, 2007) — The Biotechnology Industry Organization (BIO) today launched a new program,...